secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIO-TECHNE Corp (TECH)
CIK:        0000842023
Form:       8-K
Filed at:   2023-01-31T23:59:59+00:00
Accession:  0001558370-23-000715
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bio-Techne appoints Shane Bohnen as SVP, General Counsel; Brenda Furlow retires March 3, 2023
--------------------------------------------------------------------------------

- Shane Bohnen, previously Associate General Counsel since 2019, becomes Senior VP, General Counsel effective March 3, 2023.
- Brenda Furlow, EVP & General Counsel for nine years, retires March 3, 2023; will remain as consultant for special projects.
- Bohnen's compensation: $331,500 base salary, 50% target cash bonus, one-time $500,000 RSU grant vesting over three years.
- Bohnen has over 20 years legal experience including private practice and in-house at Smiths Medical and Resideo.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/842023/000155837023000715/0001558370-23-000715-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/842023/000155837023000715/tmb-20230126x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-000715

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer